Breeze Smoke vaping products are not FDA approved. The FDA denied the company’s application to market its electronic nicotine delivery products, and that denial was upheld by a federal appeals court. As of 2024, the FDA continues to issue warning letters against the sale of Breeze vaping products in the United States. If you’re searching about a different Breeze product, such as the Breeze 2 blood glucose monitor, that device did receive FDA clearance back in 2006, though “clearance” and “approval” mean different things.
Breeze Vape Products: FDA Denied
Breeze Smoke, LLC submitted Premarket Tobacco Product Applications (PMTAs) for its electronic nicotine delivery systems. The FDA denied those applications, citing a lack of longitudinal cohort studies, randomized controlled trials, and insufficient evidence overall. Without an approved PMTA, a vaping product cannot be legally marketed in the United States if it wasn’t already on the market before February 15, 2007.
Breeze Smoke challenged the denial in the U.S. Court of Appeals for the Sixth Circuit, arguing that the marketing denial order took effect immediately and made seeking a stay from the FDA impracticable. The court denied the company’s motion for a stay, leaving the FDA’s marketing denial order in place.
This means every Breeze vape product currently sold in the U.S. is being sold without FDA authorization. The products are considered “adulterated” and “misbranded” under federal law.
FDA Enforcement Against Breeze Sales
The FDA hasn’t just denied the application and moved on. In September 2024, the agency’s Center for Tobacco Products issued a warning letter to a website selling Breeze products, specifically flagging the Breeze Prime 6000 Puffs Strawberry Apple. The letter stated that the product lacks a marketing authorization order, is not exempt from that requirement, and is therefore illegal to sell or distribute to U.S. customers.
The warning letter gave the seller 15 working days to respond with a plan to stop selling the product and maintain compliance going forward. These warning letters are a common enforcement tool the FDA uses before escalating to seizures, injunctions, or other legal action. The fact that Breeze products still appear in stores and online doesn’t mean they’re legal. It reflects the gap between FDA enforcement capacity and the sheer volume of unauthorized vaping products on the market.
What This Means If You Use Breeze Vapes
A product without FDA authorization hasn’t gone through the safety and public health review that the PMTA process requires. That review looks at things like the toxicology of the product’s ingredients, its appeal to young people, and whether there’s evidence it could help adult smokers transition away from cigarettes. Breeze Smoke’s application failed to meet that standard.
You can still find Breeze products for sale at convenience stores and online retailers, but their legal status is clear: they are not authorized for sale. Retailers who continue selling them risk FDA enforcement action.
The Breeze 2 Blood Glucose Monitor Is a Different Story
If your search was about the Ascensia Breeze 2 Blood Glucose Monitoring System, that device received FDA clearance in November 2006. It’s classified as an over-the-counter blood glucose test system.
There’s an important distinction here. The Breeze 2 monitor was “cleared” through the FDA’s 510(k) pathway, not “approved.” These terms get used interchangeably in everyday conversation, but they represent different levels of review. A 510(k) clearance means the manufacturer demonstrated that its device is substantially equivalent to another legally marketed device. It’s a lower bar than Premarket Approval (PMA), which requires the manufacturer to submit extensive scientific evidence proving the device is safe and effective on its own merits. Most common medical devices, like glucose monitors, blood pressure cuffs, and thermometers, reach the market through 510(k) clearance rather than full PMA approval.
For practical purposes, a 510(k)-cleared glucose monitor has been reviewed by the FDA and is legal to sell and use. The Breeze 2 met that standard. However, it’s an older device, and newer continuous and flash glucose monitoring options have largely replaced traditional fingerstick monitors for many users.